# Teradyne (TER) — InvestMoat Analysis

_Last analyzed: September 25, 2026_
_Asset class: equity · Canonical page: https://investmoat.com/stocks/ter_

## Scores

| Dimension | Score (0–100) |
| --- | --- |
| Moat durability | 54 |
| Growth trajectory | 71 |
| Valuation | 60 |
| **Composite** | **59** |

Scores are computed deterministically from this asset’s data by the InvestMoat formula (see https://investmoat.com/llms.txt for methodology). Scores are not directly comparable across asset classes.

## Key stats

- **Ticker:** TER
- **Market Cap:** ~$61B
- **Price:** ~$389

## Moat

Teradyne is a two-sided play on the robot boom: it owns half of the semiconductor automated-test-equipment duopoly that every AI and robot chip must pass through, and it owns Universal Robots and MiR, the market-leading collaborative-robot and autonomous-mobile-robot franchises.

### The Gatekeeper and the Cobot Leader

Teradyne's moat is strongest exactly where the robot boom is most capital-intensive — **at the test gate for silicon and at the cobot standard on the factory floor**:

- **The ATE Duopoly:** In system-on-chip automated test equipment, Teradyne and Advantest form an effective duopoly. A chipmaker develops its test program against a specific Teradyne platform (UltraFLEX/UltraFLEXplus), correlates yield data to it, and qualifies it into high-volume production. Re-porting that test program and re-correlating to a competitor's tester is expensive and risky, so incumbency at a given customer is durable across product generations — and AI accelerators and robot SoCs are among the most test-intensive silicon ever built.
- **Universal Robots — the Cobot Standard:** Universal Robots defined the collaborative-robot category and remains its share leader, with the UR+ ecosystem of certified grippers, vision systems, and application kits acting as a genuine platform network effect. Integrators and end-users trained on UR's interface, and the library of deployed applications, make UR the default cobot spec — the same install-base dynamic that protects the industrial-automation incumbents, at the human-scale end of the market.
- **Wafer-to-AI-Datacenter Positioning:** With roughly 70% of revenue tied to AI-related demand, Teradyne sells into the entire arc from wafer test through to the robots that build and move physical goods. Q1 2026 revenue rose 87% YoY on AI and data-center test demand, while the robotics segment posted its fourth consecutive quarter of growth. Teradyne monetises the boom whether the winning chip is NVIDIA's or a custom accelerator, and whether the robot is a cobot or a humanoid — a picks-and-shovels breadth that individual robot bets lack.

**Moat verdict:** Teradyne is a net beneficiary of both AI and the robot boom — its ATE duopoly is the test gate for the most test-intensive silicon ever built, and Universal Robots is the cobot standard, both of which AI adoption accelerates rather than threatens. The genuine risks are cyclical rather than structural: semiconductor test demand swings with capex, robotics is still sub-scale, and a ~66× multiple leaves little room for disappointment.

### Top competitors

- **Advantest (6857.T):** Semiconductor test leader, strong in AI chips and memory.
- **[FANUC (FANUY)](https://investmoat.com/stocks/fanuc):** CRX cobots against Universal Robots.

## Growth

Q2 2026 revenue was a record $1.329B (+104% YoY, above the top of the $1.15–1.25B guide), after $1.28B (+87%) in Q1. Semiconductor test was $1.122B (+128% YoY), with compute test up nearly 600% on AI accelerators and record memory test on DRAM and a NAND final-test resurgence; product test was $107M (+26%) and robotics $100M (+33%, about the same pace as Q1's $91M against $69M). AI-related demand was more than 60% of sales. Non-GAAP gross margin was 59.8%, down from 60.9% in Q1 but up 250bp YoY, and Q3 is guided to $1.20–1.30B revenue at a 58–59% gross margin on new-product mix. The growth is powerful but genuinely cyclical — ATE demand swings with the semiconductor capex cycle — so the trajectory is high but the amplitude and the rich starting multiple both matter to forward returns.

- **Revenue CAGR estimate:** 12-18%
- **Primary type:** both
- **Margin trend:** stable
- **Key risk (high):** A semiconductor capex down-cycle cuts ATE orders sharply while the still-small robotics segment cannot offset it, and a ~66× multiple de-rates hard on any growth disappointment.
- **Drivers:**
  - Semiconductor Test — $1.122B in Q2'26 (+128% YoY) after $1.11B in Q1; compute test up nearly 600% YoY; record memory test on DRAM and NAND final test (accelerating)
  - Robotics — $100M in Q2'26 (+33% YoY) after $91M in Q1 (+32% vs $69M) (stable)
  - Product Test — $107M in Q2'26 (+26% YoY) after $80M in Q1 (stable)
- **Score derivation:** Base 80 (12-18% CAGR, midpoint 15%, measured from the peak-cycle 2026 base) + 1.3 trajectory (semiconductor test accelerating to +128% YoY in Q2 as company growth went from +87% to +104%; robotics steady at ~+33% in both quarters and product test +26% are stable: (1 − 0) / 3 × 4) + 0 margin (stable: non-GAAP gross margin 60.9% in Q1 → 59.8% in Q2, still +250bp YoY, with Q3 guided 58–59% on mix — neither expanding nor a structural compression) − 10 high risk (a semiconductor capex down-cycle cutting ATE orders, graded with KEYS and AMKR in the test-and-packaging cohort). Robotics moves from accelerating to stable on the Q2 print. The FY2026 Outlook line, held stable earlier today as a guidance roll-up, is replaced by the product test revenue line it was rolling up; the effect on trajectory is the same = 71

## Valuation

At ~$389 (September 23, 2026 close, $389.14) Teradyne sits ~11% above the reset base ($350) and ~23% of the way to the $520 bull, ~66% above the $235 bear — piecewise 60. The July ladder put the base at $380, above the then-$359 price, which scored the stock as cheap while this description called it demanding; the ladder is now anchored on Street 2027 EPS so the two agree. At ~$61B market cap (~157M diluted shares) TER trades at ~51× trailing non-GAAP EPS ($7.68 across Q3'25–Q2'26) and ~33× the ~$11.64 2027 consensus. Base is 30× that consensus, bear 25× the low 2027 estimate ($9.33), bull 38× the high ($13.66). Q2 revenue was $1.329B (+104%) with non-GAAP EPS $2.47, but the Q3 guide ($1.20–$1.30B, non-GAAP EPS $1.85–$2.15) steps down sequentially — the multiple is paying for 2027 rather than the next print. This is a high-quality name at a demanding price, better accumulated on cyclical weakness than chased after the AI-test re-rating.

## Price scenarios

### Bear — $235

The semiconductor test cycle rolls over as AI-accelerator test intensity is pulled forward, 2027 EPS lands at the low end of the Street range, and the multiple compresses to ~25× — still above a classic semi-cap trough multiple.

- AI-accelerator and datacenter test demand normalises after a pull-forward; the Q3 2026 sequential step-down ($1.20–$1.30B guide vs $1.329B in Q2) proves the start of an air pocket rather than a pause
- Advantest presses share in high-performance SoC test, capping Teradyne's pricing and unit gains through the down-cycle
- Robotics (~$100M a quarter in Q2) remains too small to offset semiconductor-test cyclicality when it matters most
- 25× the ~$9.33 low 2027 EPS estimate → ~$235/share (~40% below $389)

### Base — $350

AI-test demand stays structurally elevated, Teradyne holds its ATE duopoly position, 2027 EPS lands at the ~$11.64 consensus, and the market pays ~30× — in line with the KEYS test peer's high-20s/low-30s multiple — rather than re-rating further.

- AI accelerators, HBM, and custom silicon keep test intensity structurally higher; ~70% of Q1 2026 revenue was AI-linked
- Semiconductor Test ($1.122B in Q2) holds a durable step-up in baseline ATE demand through 2027
- Universal Robots and MiR sustain growth as cobots and mobile robots scale on factory and logistics floors
- 30× ~$11.64 2027 consensus EPS → ~$350/share

### Bull — $520

A physical-AI supercycle drives both sides of the business at once — humanoid and mobile-robot SoCs become a major new test-intensive category, 2027 EPS reaches the top of the Street range, and Teradyne holds a premium ~38× multiple.

- Humanoid and edge-robot silicon becomes a large new ATE end-market, extending the test-intensity tailwind well beyond datacenter accelerators
- Universal Robots and MiR inflect from ramp to scale as labor shortages and reshoring pull cobot and AMR adoption into a mass-deployment phase
- Teradyne is recognised as the diversified wafer-to-robot toll-taker on physical AI and holds a premium multiple on a much larger earnings base
- 38× the ~$13.66 high 2027 EPS estimate → ~$520/share

---

InvestMoat is a research and education framework. Nothing here is financial advice. Past performance does not guarantee future results.